FREDUN Stock Chart & Stats
₹1435.15
--
Market closed
₹1435.15
--
Day’s Range― - ―
52-Week Range₹376.67 - ₹1,600.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
₹24.64B
Enterprise Value₹11.66K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)52.2
Beta0.42
Next Earnings
Nov 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.94
Shares Outstanding16,538,070
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FREDUN FAQ
What was Fredun Pharmaceuticals Ltd.’s price range in the past 12 months?
Fredun Pharmaceuticals Ltd. lowest stock price was ₹376.67 and its highest was ₹1600.00 in the past 12 months.
What is Fredun Pharmaceuticals Ltd.’s market cap?
Fredun Pharmaceuticals Ltd.’s market cap is ₹24.64B.
When is Fredun Pharmaceuticals Ltd.’s upcoming earnings report date?
Fredun Pharmaceuticals Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 69 days.
How were Fredun Pharmaceuticals Ltd.’s earnings last quarter?
Fredun Pharmaceuticals Ltd. released its earnings results on Aug 05, 2026. The company reported ₹7.941 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Fredun Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Fredun Pharmaceuticals Ltd.’s price is currently Overvalued.
Does Fredun Pharmaceuticals Ltd. pay dividends?
Fredun Pharmaceuticals Ltd. does not currently pay dividends.
What is Fredun Pharmaceuticals Ltd.’s EPS estimate?
Fredun Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fredun Pharmaceuticals Ltd. have?
Fredun Pharmaceuticals Ltd. has 16,538,070 shares outstanding.
What happened to Fredun Pharmaceuticals Ltd.’s price movement after its last earnings report?
Fredun Pharmaceuticals Ltd. reported an EPS of ₹7.941 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 18.342%.
Which hedge fund is a major shareholder of Fredun Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:FREDUN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology